PT-141 serves as a cutting-edge cyclic melanocortin agonist that demonstrates potential in the treatment of sexual dysfunction. This novel compound operates by stimulating specific receptors across the body, leading to augmented sexual function. Preclinical studies have revealed that PT-141 may remarkably treat a variety of sexual dysfunctions in